Adriana Feder

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Patent
    Ineligible company:
    Patent licensed to Frontier Pharma
    Topic:
    Patents on use of ketamine for PTSD treatment
    Date added:
    04/29/2026
    Date updated:
    04/29/2026
    Relationship end date:
    04/29/2029
Return to 124 Ken Altshuler, MD Grand Rounds In Psychiatry (FY26): “Ketamine for Chronic PTSD: Treatment Development and Future Directions” (050626)

 

**Disclaimer**

This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.